Clinical Trial of Epsilon-aminocaproic Acid in Severe Haemophilia
- 26 June 1965
- Vol. 1 (5451), 1632-1635
- https://doi.org/10.1136/bmj.1.5451.1632
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACIDThe Lancet, 1964
- HÆMATURIA IN A HÆMOPHILIAC TREATED WITH E-AMINOCAPROIC ACIDThe Lancet, 1964
- THE USE OF EPSILON-AMINOCAPROIC ACID IN THE MANAGEMENT OF DENTAL EXTRACTIONS IN THE HEMOPHILIACThe American Journal of the Medical Sciences, 1964
- In-vitro and In-vivo Studies of a Preparation of UrokinaseBMJ, 1963
- Fibrinolytic mechanisms and the development of thrombolytic therapyAmerican Journal Of Medicine, 1962
- Problems in Hemostasis During Open-Heart Surgery III. Epsilon Amino Caproic Acid as an Inhibitor of Plasminogen Activator ActivityAnnals of Surgery, 1962
- Studies on Spontaneous Fibrinolytic Activity In Patients with Cirrhosis of the Liver and Its Inhibition by Epsilon Amino Caproic AcidAnnals of Surgery, 1961
- Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by ϵ-aminocaproic acidArchives of Biochemistry and Biophysics, 1959
- THE BIOLOGICAL SIGNIFICANCE OF FIBRINOLYSISThe Lancet, 1956
- A Brain Extract as a Substitute for Platelet Suspensions in the Thromboplastin Generation TestNature, 1954